![]() |
|
Nanoform's CEO, Professor Edward Hæggström, and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca — a long term partner of Nanoform — discuss the potential of nanoscale medicines and delivery devices to benefit patients.
|